Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2-(butylamino)propan-2-yl)phosphinic Acid
2. Butaphosphan
1. 17316-67-5
2. Butaphosphan
3. 2-(butylamino)propan-2-yl-hydroxy-oxophosphanium
4. [2-(butylamino)propan-2-yl]phosphinic Acid
5. Phosphinic Acid, [1-(butylamino)-1-methylethyl]-
6. 1-(butylamino)-1-methylethyl]-phosphonic Acid
7. 3q2lq1149l
8. Ncgc00249608-01
9. 2-(butylamino)propan-2-ylphosphinic Acid
10. (1-(butylamino)-1-methylethyl)phosphinic Acid
11. Butafosfano
12. Butafosfanum
13. 1-(butylamino)-1-methylethyl)-phosphonic Acid
14. Butafosfan [inn:ban]
15. Sr-01000945191
16. Butafosfanum [inn-latin]
17. Butafosfano [inn-spanish]
18. Butapho
19. Unii-3q2lq1149l
20. Einecs 241-341-7
21. 1-(buylamino-1-methyl)ethylphosphinsaeure
22. Butafosfan [inn]
23. Dsstox_cid_28607
24. Dsstox_rid_82877
25. Dsstox_gsid_48681
26. Schembl2110672
27. Chembl1979022
28. Dtxsid5048681
29. Dtxsid00860202
30. Bcp12944
31. Tox21_113065
32. Mfcd00869071
33. Stl135983
34. Zinc38322248
35. Zinc95913251
36. Akos005746929
37. Akos015918370
38. Ncgc00249608-02
39. As-15854
40. 2-(butylamino)propan-2-yl)phosphinic Acid
41. Cas-17316-67-5
42. Ft-0623297
43. [1-(butylamino)-1-methyl-ethyl]phosphinic Acid
44. 316b675
45. A811490
46. Phosphinic Acid, (1-(butylamino)-1-methyethyl)-
47. J-010881
48. Sr-01000945191-1
49. Sr-01000945191-2
50. (2-(butylamino)propan-2-yl)(hydroxy)(oxo)phosphonium
51. Phosphinic Acid, P-[1-(butylamino)-1-methylethyl]-
52. Q27257890
53. 1-( N-butylamino)-1-methylethyl Phosphonous Acid
Molecular Weight | 178.19 g/mol |
---|---|
Molecular Formula | C7H17NO2P+ |
XLogP3 | 0.7 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 5 |
Exact Mass | 178.09969078 g/mol |
Monoisotopic Mass | 178.09969078 g/mol |
Topological Polar Surface Area | 49.3 Ų |
Heavy Atom Count | 11 |
Formal Charge | 1 |
Complexity | 136 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Market Place
ABOUT THIS PAGE
53
PharmaCompass offers a list of Butafosfan API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Butafosfan manufacturer or Butafosfan supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Butafosfan manufacturer or Butafosfan supplier.
PharmaCompass also assists you with knowing the Butafosfan API Price utilized in the formulation of products. Butafosfan API Price is not always fixed or binding as the Butafosfan Price is obtained through a variety of data sources. The Butafosfan Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A butaphosphan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of butaphosphan, including repackagers and relabelers. The FDA regulates butaphosphan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. butaphosphan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of butaphosphan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A butaphosphan supplier is an individual or a company that provides butaphosphan active pharmaceutical ingredient (API) or butaphosphan finished formulations upon request. The butaphosphan suppliers may include butaphosphan API manufacturers, exporters, distributors and traders.
click here to find a list of butaphosphan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing butaphosphan as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for butaphosphan API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture butaphosphan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain butaphosphan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a butaphosphan NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of butaphosphan suppliers with NDC on PharmaCompass.
butaphosphan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of butaphosphan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right butaphosphan GMP manufacturer or butaphosphan GMP API supplier for your needs.
A butaphosphan CoA (Certificate of Analysis) is a formal document that attests to butaphosphan's compliance with butaphosphan specifications and serves as a tool for batch-level quality control.
butaphosphan CoA mostly includes findings from lab analyses of a specific batch. For each butaphosphan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
butaphosphan may be tested according to a variety of international standards, such as European Pharmacopoeia (butaphosphan EP), butaphosphan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (butaphosphan USP).